Article

Challenges of treating peripheral hemorrhagic polypoidal choroidal vasculopathy

Author(s):

Lynda Charters
Conferences|EURETINA

A case study details the care of a patient who had already lost vision in one eye from a similar issue.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(mage credit: Ophthalmology Times) S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
Related Content
From blindness to breakthrough: Milestones that changed ophthalmology forever
August 5th 2025

From blindness to breakthrough: Milestones that changed ophthalmology forever

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 5th 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Q&A: The potential impact of vitamin D on retinal surgery
August 5th 2025

Q&A: The potential impact of vitamin D on retinal surgery

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
August 5th 2025

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Q&A: Updates on faricimab for DME from ASRS 2025
August 5th 2025

Q&A: Updates on faricimab for DME from ASRS 2025

Q&A: A VERONA trial update with Yasha S. Modi, MD
August 5th 2025

Q&A: A VERONA trial update with Yasha S. Modi, MD

© 2025 MJH Life Sciences

All rights reserved.